The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
THE ROLE OF INTESTINAL BACTERIA IN THE DEVELOPMENT OF DIETARY CIRRHOSIS IN RATS
Open accessAbstract
Diffuse hepatic cirrhosis develops in rats on a choline-deficient diet within 300 days. Absorbable broad spectrum antibiotics added to the daily diet do not prevent the development of fatty infiltration, but they delay the development of cirrhosis for about 100 days more. Non-absorbable antibiotics added to the daily diet prevent the development of cirrhosis in most rats for as long as 750 days. The superiority of non-absorbable antibiotics to absorbable antibiotics excludes a systemic effect of the antibiotics and demonstrates that intestinal bacteria are largely, if not wholly, responsible for the cirrhosis in rats on a choline-deficient diet.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There is strong evidence for an important contribution of the microbiota–TLR4 axis to liver fibrosis.”
From The gut microbiome and liver cancer: mechanisms and clinical translation (2017) · cites this paper as [72]
In the citing paper
“Studies from the past six decades have shown that antibiotics prevent hepatic injury and fibrosis induced by CCl4 treatment, bile duct ligation or a choline-deficient diet, and that endotoxin enhances hepatic fibrosis induced by a choline-deficient diet71–73.”
From The gut microbiome and liver cancer: mechanisms and clinical translation (2017) · cites this paper as [72]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lectures on the Liver and Its Diseases.
(1949) · Archives of Internal Medicine · doi:10.1001/archinte.1949.00220350132010 · Cited by 165
Copeland, D. H., & Salmon, W. D. (1946) · PubMed · Cited by 150
Lectures on the Liver and its Diseases
Himsworth, H. P. (1950) · Cited by 125
Griffith, W. H., & Wade, N. J. (1939) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)73454-6 · Cited by 123
GROWTH-promoting effect of aureomycin on pigs.
Jukes, T. H., Stokstad, E. L. R., Tayloe, R. R., Cunha, T. J. F., Edwards, H. M., & Meadows, G. B. (1950) · PubMed · Cited by 110
THE SEQUENCE OF PATHOLOGIC EVENTS IN THE DEVELOPMENT OF EXPERIMENTAL FATTY LIVER AND CIRRHOSIS
Hartroft, W. S. (1954) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1954.tb36440.x · Cited by 62
Fatty Liver Following Aureomycin and Terramycin Therapy in Chronic Hepatic Disease
Sborov, V. M., & Sutherland, D. A. (1951) · Gastroenterology · doi:10.1016/s0016-5085(51)80131-8 · Cited by 56
GERMFREE ANIMALS AND LIVER NECROSIS
Luckey, T. D., Reyniers, J. A., György, P., & Forbes, M. (1954) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1954.tb36472.x · Cited by 52
Polymyxin B and polymyxin E; clinical and laboratory studies.
Kagan, B. M., KREVSKY, D. A., MILZER, A., & Locke, M. (1951) · PubMed · Cited by 44
LABORATORY AND CLINICAL STUDIES OF POLYMYXIN B AND E 12
Pulaski, E. J., Baker, H. J., Rosenberg, M. L., & Connell, J. F. (1949) · Journal of Clinical Investigation · doi:10.1172/jci102134 · Cited by 42
Flagged first, then by citations
Cited by
Sorted by citations
The gut-liver axis and the intersection with the microbiome
Tripathi, A., Debelius, J., Brenner, D. A., Karin, M., Loomba, R., Schnabl, B., & Knight, R. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0011-z · Cited by 1,480
Promotion of Hepatocellular Carcinoma by the Intestinal Microbiota and TLR4
Dapito, D. H., Mencin, A., Gwak, G.-Y., Pradere, J.-P., Jang, M.-K., Mederacke, I., Caviglia, J. M., Khiabanian, H., Adeyemi, A., Bataller, R., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.007 · Cited by 1,346
NF-κB in the liver—linking injury, fibrosis and hepatocellular carcinoma
Luedde, T., & Schwabe, R. F. (2011) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.213 · Cited by 1,345
The gut microbiome and liver cancer: mechanisms and clinical translation
Yu, L.-X., & Schwabe, R. F. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.72 · Cited by 634
Lipopolysaccharides in liver injury: molecular mechanisms of Kupffer cell activation
Su, G. L. (2002) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00550.2001 · Cited by 486
Toll-Like Receptor Signaling in the Liver
Schwabe, R. F., Seki, E., & Brenner, D. A. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.01.038 · Cited by 412
Leaky Gut in Alcoholic Cirrhosis: A Possible Mechanism for Alcohol-Induced Liver Damage
Keshavarzian, A., HOLMES, E. W., Patel, M., Iber, F. L., Fields, J. Z., & Pethkar, S. (1999) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.00797.x · Cited by 381
The role of lipopolysaccharide/toll-like receptor 4 signaling in chronic liver diseases
Soares, J., Pimentel‐Nunes, P., Roncon‐Albuquerque, R., & Leite-Moreira, A. F. (2010) · Hepatology International · doi:10.1007/s12072-010-9219-x · Cited by 378
Endotoxin, reticuloendothelial function, and liver injury
Nolan, J. P. (1981) · Hepatology · doi:10.1002/hep.1840010516 · Cited by 359
Toll-like receptors as targets in chronic liver diseases
Mencin, A. M., Kluwe, J., & Schwabe, R. F. (2009) · Gut · doi:10.1136/gut.2008.156307 · Cited by 338
Bacterial translocation and changes in the intestinal microbiome in mouse models of liver disease
Fouts, D. E., Torralba, M., Nelson, K. E., Brenner, D. A., & Schnabl, B. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.01.019 · Cited by 311
The Role of Endotoxin in Liver Injury
Nolan, J. P. (1975) · Gastroenterology · doi:10.1016/s0016-5085(19)32333-9 · Cited by 283
The Role of Intestinal Endotoxin in Liver Injury: A Long and Evolving History
Nolan, J. P. (2010) · Hepatology · doi:10.1002/hep.23917 · Cited by 229
Intestinal Endotoxins As Mediators of Hepatic Injury—An Idea Whose Time Has Come Again
Nolan, J. P. (1989) · Hepatology · doi:10.1002/hep.1840100523 · Cited by 203
Czaja, M. J., Xu, J., & Alt, E. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90149-3 · Cited by 186
Intestinal Microbiota and Nonalcoholic Steatohepatitis
Brandl, K., & Schnabl, B. (2017) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000349 · Cited by 169
Attenuation of CCl 4 -induced hepatic fibrosis by GdCl 3 treatment or dietary glycine
Rivera, C. A., Bradford, B. U., Hunt, K. J., Adachi, Y., Schrum, L. W., Koop, D. R., Burchardt, E.-R., Rippe, R. A., & Thurman, R. G. (2001) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2001.281.1.g200 · Cited by 165
Roth, R. A., Harkema, J. R., Pestka, J. J., & Ganey, P. E. (1997) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1997.8301 · Cited by 160
Toll-like Receptor 4 and Hepatic Fibrogenesis
Pradere, J.-P., Troeger, J., Dapito, D., Mencin, A., & Schwabe, R. (2010) · Seminars in Liver Disease · doi:10.1055/s-0030-1255353 · Cited by 158
Regulation of wound healing and organ fibrosis by toll-like receptors
Huebener, P., & Schwabe, R. F. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.11.017 · Cited by 140
Alcohol and its Relation to Liver Damage
Klatskin, G. (1961) · Gastroenterology · doi:10.1016/s0016-5085(19)35088-7 · Cited by 132
Nolan, J. P., & Leibowitz, A. I. (1978) · Gastroenterology · doi:10.1016/0016-5085(78)90848-x · Cited by 121
Metagenomics of the Human Body
Nelson, K. E. (2010) · Springer eBooks · doi:10.1007/978-1-4419-7089-3 · Cited by 118
Portal and systemic bacteraemia and endotoxaemia in liver disease.
Triger, D. R., BOYER, T. D., & Levin, J. (1978) · Gut · doi:10.1136/gut.19.10.935 · Cited by 114
The role of gut microbiota in non-alcoholic fatty liver disease: pathways of mechanisms
Jasirwan, C. O. M., Lesmana, C. R. A., Hasan, I., Sulaiman, A. S., & Gani, R. A. (2019) · Bioscience of Microbiota Food and Health · doi:10.12938/bmfh.18-032 · Cited by 114
Concurrent inflammation as a determinant of susceptibility to toxicity from xenobiotic agents
Ganey, P. E., & Roth, R. A. (2001) · Toxicology · doi:10.1016/s0300-483x(01)00523-6 · Cited by 100
Broitman, S. A., Gottlieb, L. S., & Zamcheck, N. (1964) · The Journal of Experimental Medicine · doi:10.1084/jem.119.4.633 · Cited by 99
Advances in Alcoholic Liver Disease
Beier, J. I., Arteel, G. E., & McClain, C. J. (2010) · Current Gastroenterology Reports · doi:10.1007/s11894-010-0157-5 · Cited by 98
Lau, L. H. S., & Wong, S. H. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-8684-7_9 · Cited by 93
Zhou, H.-R. (2000) · Toxicological Sciences · doi:10.1093/toxsci/53.2.253 · Cited by 84
Islam, Z., & Pestka, J. J. (2005) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2005.04.031 · Cited by 76
The Problem of Persisting Destructive Disease of the Liver
Mackay, I. R. (1961) · Gastroenterology · doi:10.1016/s0016-5085(61)80029-2 · Cited by 73
Publisher Correction: The gut–liver axis and the intersection with the microbiome
Tripathi, A., Debelius, J., Brenner, D. A., Karin, M., Loomba, R., Schnabl, B., & Knight, R. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0031-8 · Cited by 70
Toll-like receptors as therapeutic targets in gastrointestinal diseases
Pimentel‐Nunes, P., Soares, J., Roncon‐Albuquerque, R., Dinis-Ribeiro, M. J., & Leite-Moreira, A. F. (2010) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728221003642027 · Cited by 69
Islam, Z., Moon, Y., Zhou, H.-R., King, L. E., Fraker, P. J., & Pestka, J. J. (2002) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2002.9374 · Cited by 60
Czaja, M. J., Xu, J., Ju, Y., Alt, E., & Schmiedeberg, P. (1994) · Hepatology · doi:10.1002/hep.1840190529 · Cited by 59
Udden, S. M. N., Kwak, Y.-T., Godfrey, V., Khan, M. A. W., Khan, S., Loof, N., Peng, L., Zhu, H., & Zaki, H. (2019) · eLife · doi:10.7554/elife.40396 · Cited by 49
Non-Alcoholic Steatohepatitis and Hepatocellular Carcinoma: Implications for Lycopene Intervention
Ip, B. C., & Wang, X. (2013) · Nutrients · doi:10.3390/nu6010124 · Cited by 47
Floch, M. H., Katz, J., & Conn, H. O. (1970) · Gastroenterology · doi:10.1016/s0016-5085(19)33805-3 · Cited by 47
DIAGNOSIS OF PANCREATIC CARCINOMA
Hatta, Y., Taguchi, S., Sakamoto, N., Suzawa, S., KOYAMA, M., Kato, K. H., & Miyazaki, H. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92416-2 · Cited by 46
Potential Role of the Gut/Liver/Lung Axis in Alcohol-Induced Tissue Pathology
Massey, V. L., Beier, J. I., Ritzenthaler, J. D., Roman, J., & Arteel, G. E. (2015) · Biomolecules · doi:10.3390/biom5042477 · Cited by 45
Organ–Organ Crosstalk and Alcoholic Liver Disease
Poole, L. G., Dolin, C. E., & Arteel, G. E. (2017) · Biomolecules · doi:10.3390/biom7030062 · Cited by 42
An etiologic basis for fatty liver after jejunoileal bypass
Hollenbeck, J. I., O’Leary, J. P., Maher, J. W., & Woodward, E. R. (1975) · Journal of Surgical Research · doi:10.1016/0022-4804(75)90002-5 · Cited by 42
Hepatic Fibrosis and Cirrhosis
Rockey, D. C. (2015) · Wiley eBooks · doi:10.1002/9781118512074.ch105 · Cited by 41
Contributions of the Intestinal Microflora to the Nutrition of the Host
HÖzel, D., & Barnes, R. H. (1967) · Vitamins and hormones · doi:10.1016/s0083-6729(08)60204-6 · Cited by 38
Escherichia coliAntibodies in Alcoholic Liver Disease
Staun‐Olsen, P., Bjørneboe, M., Prytz, H., Thomsen, A. C., & Ørskov, F. (1983) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365528309182111 · Cited by 38
Fatty livers and lipotropic phenomena
Lucas, C. C., & Ridout, J. H. (1970) · Progress in the Chemistry of Fats and other Lipids · doi:10.1016/0079-6832(70)90004-2 · Cited by 33
Massey, V. L., Stocke, K. S., Schmidt, R. H., Tan, M., Ajami, N. J., Neal, R. E., Petrosino, J. F., Barve, S. S., & Arteel, G. E. (2015) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2015.02.022 · Cited by 29
Salmon, W. D., & Newberne, P. M. (1962) · Journal of Nutrition · doi:10.1093/jn/76.4.483 · Cited by 27
Crosstalk between NLRP12 and JNK during Hepatocellular Carcinoma
Khan, S., & Zaki, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020496 · Cited by 27
Endotoxins and the Pathogenesis of Hepatic and Gastrointestinal Diseases
Liehr, H. (1982) · Springer eBooks · doi:10.1007/978-3-642-68307-7_3 · Cited by 26
Liver-lung axes in alcohol-related liver disease
Arteel, G. E. (2020) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2020.0174 · Cited by 27
The contribution of gut-derived endotoxins to liver injury.
Jp, N. (1979) · PubMed Central · Cited by 21
Nutritional Laennec's cirrhosis in the Macaca mulatta monkey
Gaisford, W. D., & Zuidema, G. D. (1965) · Journal of Surgical Research · doi:10.1016/s0022-4804(65)80090-7 · Cited by 21
Anti-inflammatory and anti-oxidative activities of lemon myrtle (Backhousia citriodora) leaf extract
Shim, S.-Y., Kim, J., Kho, K. H., & Lee, M. (2020) · Toxicology Reports · doi:10.1016/j.toxrep.2020.01.018 · Cited by 20
Wilkinson, S. P. (1977) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365527709181676 · Cited by 20
Pritchard, M. T., & McCracken, J. M. (2015) · Current Drug Targets · doi:10.2174/1389450116666150825111439 · Cited by 19
Levenson, S. Μ., Nagler, A. L., Geever, E. F., & Seifter, E. (1968) · Journal of Nutrition · doi:10.1093/jn/95.2.247 · Cited by 16
What is the potential role of antifibrotic agents for the treatment of liver disease?
Schnabl, B., Scholten, D., & Brenner, D. A. (2008) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep1200 · Cited by 15
The Influence of the Indigenous Microflora on Mammalian Metabolism and Nutrition
Levenson, S. Μ. (1978) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/014860717800200203 · Cited by 15
Hepatic Fibrosis and Cirrhosis
Rockey, D. C., & Friedman, S. L. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0881-3.00005-x · Cited by 13
Simple Determination of the L.E. Factor
van Soeren, F. (1961) · Annals of the Rheumatic Diseases · doi:10.1136/ard.20.3.281 · Cited by 12
Bjørneboe, M., & Prytz, H. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92415-0 · Cited by 12
Alcohol, Altered Gut Permeability, and Endotoxins
Parlesak, A. (2005) · Elsevier eBooks · doi:10.1016/b978-012564370-2/50077-5 · Cited by 11
The mononuclear phagocytic functions of the liver
Bjørneboe, M., & Prytz, H. (1976) · Springer eBooks · doi:10.1007/978-94-011-6150-3_7 · Cited by 10
Immunologic Dyshomeostasis in Multiple Organ Failure: The Gut-Liver Axis
Marshall, J. C. (1993) · Springer eBooks · doi:10.1007/978-3-642-77405-8_26 · Cited by 9
Toll-like receptor signaling in the liver
Seki, E., Brenner, D. A., & Schwabe, R. F. (2006) · Birkhäuser Basel eBooks · doi:10.1007/3-7643-7441-1_7 · Cited by 9
Pathogenesis of Alcoholic Liver Disease
Arteel, G. E., & Crabb, D. W. (2015) · Springer eBooks · doi:10.1007/978-3-319-20538-0_3 · Cited by 8
Aflatoxin Carcinogenesis in Rats: Dietary Effects
Newberne, P. M., & Rogers, A. E. (1971) · Palgrave Macmillan UK eBooks · doi:10.1007/978-1-349-01318-0_19 · Cited by 8
Nutritional Factors in Liver Disease in Man
Leevy, C. M. (1959) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/7.2.146 · Cited by 8
Hulse, A. S. R. G. K. (2014) · Journal of Forensic Toxicology and Pharmacology · doi:10.4172/2325-9841.1000126 · Cited by 7
BACTERIOLOGIC CULTURE OF THE DISEASED HUMAN LIVER
Stormont, J. M., Mackie, J. E., Kass, E. H., & Davidson, C. S. (1959) · Annals of Internal Medicine · doi:10.7326/0003-4819-51-1-17 · Cited by 7
Mankowski, Z. T. (1964) · Mycopathologia · doi:10.1007/bf02049061 · Cited by 7
Intestinal endotoxins and macrophages as mediators of liver injury.
Nolan, J. P., & Camara, D. S. (1989) · PubMed Central · Cited by 6
Ethanol-Induced Hepatotoxicity
Beier, J. I., & Arteel, G. E. (2010) · Elsevier eBooks · doi:10.1016/b978-0-08-046884-6.01017-4 · Cited by 4
Intestinal Endotoxin and the Host
Ravin, H. A. (1963) · Gastroenterology · doi:10.1016/s0016-5085(63)80122-5 · Cited by 4
HYPERGLOBULINÆMIA IN LIVER DISEASE
Prytz, H., & Bjørneboe, M. (1973) · The Lancet · doi:10.1016/s0140-6736(73)93094-8 · Cited by 4
Structural and Morphological Changes in the Liver Due to Intestinal Endotoxins
Малев, А. Л., Zakharova, A. N., Kaliberdenko, V. B., Fominykh, T. A., Kulanthaivel, S., & Balasundaram, K. (2020) · Reviews on Recent Clinical Trials · doi:10.2174/1574887115666200617143422 · Cited by 3
Viddal, K. O., Midtvedt, T., & Nygaard, K. (1983) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365528309181648 · Cited by 3
Current status of some aspects of parenteral nutrition
Levenson, S. Μ. (1962) · The American Journal of Surgery · doi:10.1016/0002-9610(62)90223-4 · Cited by 3
(1982) · The Lancet · doi:10.1016/s0140-6736(82)91574-4 · Cited by 3
Klatskin, G. (1959) · Archives of Internal Medicine · doi:10.1001/archinte.1959.00270120055008 · Cited by 3
Gans, H. (1984) · Springer eBooks · doi:10.1007/978-1-4684-4574-9_6 · Cited by 3
Bacterial endotoxins and liver haemorrhage in the oestrogenised chicken
Curtis, M. J., Pearson, A. W., & Butler, E. J. (1980) · Research in Veterinary Science · doi:10.1016/s0034-5288(18)32646-8 · Cited by 2
RES Function in Experimental and Human Liver Disease
Liehr, H. (1985) · Springer eBooks · doi:10.1007/978-1-4613-2353-2_9 · Cited by 2
Endotoxins and Alcoholic Hepatitis
Liehr, H. (1983) · Springer eBooks · doi:10.1007/978-3-642-68748-8_24 · Cited by 2
EXPERIMENTAL DIETETIC INJURY OF THE LIVER
Taft, E. B. (1964) · Elsevier eBooks · doi:10.1016/b978-1-4832-2827-3.50016-6 · Cited by 2
Jung, F., Brandt, A., & Bergheim, I. (2023) · Springer eBooks · doi:10.1007/978-3-031-32483-3_61 · Cited by 1
Microbiome and Diseases: Hepatic Disorders
Bergheim, I., & Schuppan, D. (2018) · Springer eBooks · doi:10.1007/978-3-319-90545-7_17 · Cited by 1
(1982) · The Lancet · doi:10.1016/s0140-6736(82)91573-2 · Cited by 1
Extracellular matrix proteins and the liver-lung axis in disease.
Massey, V. L. (2014) · ThinkIR: The University of Louisville's Institutional Repository (University of Louisville) · doi:10.18297/etd/1752 · Cited by 1
The Nature and Sources of Natural Biliary Immunoglobulins
Jackson, G., Hansen, P. G., & Manning, R. J. (1989) · Protides of the biological fluids · doi:10.1016/b978-0-08-037378-2.50034-6 · Cited by 1
The Gut-Liver Axis in Multiple Organ Failure
Marshall, J. C. (1992) · Update in intensive care and emergency medicine · doi:10.1007/978-3-642-84827-8_16 · Cited by 1
McClain, C. J., & Barve, S. S. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.01.016 · Cited by 1
Tsung, A., & Geller, D. A. (2005) · Springer eBooks · doi:10.1007/3-540-27194-5_14
Innate Immunity in Alcohol Liver Disease
Soares, J.-B., & Pimentel‐Nunes, P. (2012) · InTech eBooks · doi:10.5772/26821
Hepatic dysfunction and malnutrition in the experimental animal
Tanner, M. S. (1986) · Elsevier eBooks · doi:10.1016/b978-0-407-00401-6.50029-4
Mechanisms of Alcoholic Steatosis/Steatohepatitis
Zhou, Z., Jones, R. E., & McClain, C. J. (2011) · Springer eBooks · doi:10.1007/978-1-4419-1712-6_6
Metagenomic Applications and the Potential for Understanding Chronic Liver Disease
Schnabl, B. (2010) · Springer eBooks · doi:10.1007/978-1-4419-7089-3_13
Clinical Relevance of Endotoxemia
Nolan, J. P. (1986) · Springer eBooks · doi:10.1007/978-1-4613-2253-5_44
Metadata
- Authors
- Rutenburg, A. M., Sonnenblick, E., Koven, I., Aprahamian, H. A., Reiner, L., & Fine, J.
- Affiliations
- Harvard University (US)
- ORCID
- Fine, Jacob
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 1957-07-01
- Volume
- 106
- Issue
- 1
- Pages
- 1-14
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2136738
- OpenAlex
- W2108335279
- Cited by
- 108
- References
- 16
- Citations by year
- 2026: 1 · 2025: 1 · 2023: 1 · 2020: 4 · 2019: 2 · 2018: 4 · 2017: 4 · 2016: 1 · 2015: 5 · 2014: 2 · 2013: 1 · 2012: 5
- FWCI
- 1.06
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Cancer Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- choline-deficient diet, intestinal bacteria, non-absorbable antibiotics, hepatic steatosis, rats
- MeSH terms
- Animals, Bacteria, Intestines, Liver Cirrhosis, Liver Cirrhosis, Experimental, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review